Skip to main content
Equibles

STATE STREET CORP

Position in LRMR — Larimar Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to LRMR Full portfolio

Position in LRMR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,306,002
+$205,035 QoQ
Shares Held
1,411,804
+54.9% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 163 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 23% Shared 0% None 77%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. LRMR ranks #224 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in LRMR

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,306,002 1,411,804
2026-03-31 $4,100,967 911,326
2025-12-31 $3,474,434 911,925
2025-09-30 $2,880,736 891,869
2025-06-30 $2,482,417 858,968
2025-03-31 $1,789,963 832,541
2024-12-31 $3,261,988 842,891
2024-09-30 $5,988,782 914,318
2024-06-30 $6,642,457 916,201
2024-03-31 $4,786,861 630,680
2023-12-31 $2,116,282 465,117
2023-09-30 $1,792,182 453,717
2023-06-30 $1,346,892 430,317
2023-03-31 $481,099 106,203
2022-12-31 $249,658 60,450
2022-09-30 $132,640 41,450
2022-06-30 $81,242 41,450
2022-03-31 $167,872 41,450
2021-12-31 $421,166 39,033
2021-09-30 $450,050 39,033
2021-06-30 $383,304 39,033